Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Emily Lesnicki"'
Autor:
Gwendolyn M. Pais, Jack Chang, Erin F. Barreto, Gideon Stitt, Kevin J. Downes, Mohammad H. Alshaer, Emily Lesnicki, Vaidehi Panchal, Maria Bruzzone, Argyle V. Bumanglag, Sara N. Burke, Marc H. Scheetz
Publikováno v:
Clin Pharmacokinet
Cefepime is a broad-spectrum fourth-generation cephalosporin with activity against Gram-positive and Gram-negative pathogens. It is generally administered as an infusion over 30-60 min or as a prolonged infusion with infusion times from 3 h to contin
Autor:
Jack Chang, Gwendolyn M. Pais, Sylwia Marianski, Kimberly Valdez, Emily Lesnicki, Erin F. Barreto, Nathaniel J. Rhodes, Paul R. Yarnold, Marc H. Scheetz
Recent clinical studies have reported additive nephrotoxicity with the combination of vancomycin and piperacillin-tazobactam. However, preclinical models have failed to replicate this finding. This study assessed differences in iohexol-measured glome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6404f69d878d40c24b8051533ecc40b
https://doi.org/10.1101/2023.03.09.532007
https://doi.org/10.1101/2023.03.09.532007
Autor:
Emily Lesnicki, Gwendolyn M. Pais, Sylwia Marianski, Kimberly Valdez, Zoe Gibson, Jeffri Christopher, Marc H. Scheetz
BackgroundIn high dose, cefepime causes neurotoxicity in patients with kidney injury; however, the relationship between exposure and observed neurotoxicity is not clear, and no animal model presently recapitulates the human condition.ObjectivesThis s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80785d8cf8ebb5feb3a91ccbd02e31e2
https://doi.org/10.1101/2022.05.26.493582
https://doi.org/10.1101/2022.05.26.493582